FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma
暂无分享，去创建一个
R. Pazdur | G. Reaman | Y. Kasamon | M. Theoret | W. Chambers | N. Gormley | Hongshan Li | Nicholas C Richardson | M. Merino | Lian Ma | R. Leong | Jiaxi Zhou | Nicholas Richardson | Ruby Leong